IGFBP6 and astrocytoma (excluding glioblastoma): Specifically, patients with glioblastoma expressed significantly higher levels of the IGFBP6 messenger in the brain than patients with oligodendroglioma (P < 0.0001), astrocytoma (P < 0.0001), or healthy subjects (P < 0.0001) (Fig. 5a).